(Approval lapsed) Metformin 500mg Prolonged Release Tablets (UK)
Section 19A approved medicine
(Approval lapsed) Metformin 500mg Prolonged Release Tablets (UK)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
DIABEX XR 500 metformin hydrochloride 500mg extended release tablet blister pack - ARTG 98982
APO-METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 281211
BLOOMS THE CHEMIST METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 278176
CHEMMART METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 197405
DIAFORMIN XR metformin hydrochloride 500mg extended release tablet blister pack - ARTG 120868
METEX XR metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 232661
TERRY WHITE CHEMISTS METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 278180
APO-METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 281211
BLOOMS THE CHEMIST METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 278176
CHEMMART METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 197405
DIAFORMIN XR metformin hydrochloride 500mg extended release tablet blister pack - ARTG 120868
METEX XR metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 232661
TERRY WHITE CHEMISTS METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 278180
Indication(s)
Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Metformin prolonged release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.